167 related articles for article (PubMed ID: 9874327)
1. The use of pamidronate in three children with renal disease.
Sellers E; Sharma A; Rodd C
Pediatr Nephrol; 1998 Nov; 12(9):778-81. PubMed ID: 9874327
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis.
Torregrosa JV; Moreno A; Mas M; Ybarra J; Fuster D
Kidney Int Suppl; 2003 Jun; (85):S88-90. PubMed ID: 12753274
[TBL] [Abstract][Full Text] [Related]
3. Pamidronate therapy as prevention of bone loss following renal transplantation.
Fan SL; Almond MK; Ball E; Evans K; Cunningham J
Kidney Int; 2000 Feb; 57(2):684-90. PubMed ID: 10652047
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.
Czosnowski LM; Hudson JQ; Canada RB
Am J Med Sci; 2009 Apr; 337(4):300-1. PubMed ID: 19365180
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant.
Torregrosa JV; Fuster D; Monegal A; Gentil MA; Bravo J; Guirado L; Muxí A; Cubero J
Osteoporos Int; 2011 Jan; 22(1):281-7. PubMed ID: 20229199
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure.
Davenport A; Goel S; Mackenzie JC
Scand J Urol Nephrol; 1993; 27(4):447-51. PubMed ID: 8159916
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.
Coco M; Glicklich D; Faugere MC; Burris L; Bognar I; Durkin P; Tellis V; Greenstein S; Schechner R; Figueroa K; McDonough P; Wang G; Malluche H
J Am Soc Nephrol; 2003 Oct; 14(10):2669-76. PubMed ID: 14514747
[TBL] [Abstract][Full Text] [Related]
8. Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury.
Massagli TL; Cardenas DD
Arch Phys Med Rehabil; 1999 Sep; 80(9):998-1000. PubMed ID: 10488998
[TBL] [Abstract][Full Text] [Related]
9. Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report.
Mahmoud S; Mitwally H; El Zeer HS; El Madhoun I; Khatib M
Am J Case Rep; 2018 Sep; 19():1087-1089. PubMed ID: 30209247
[TBL] [Abstract][Full Text] [Related]
10. Pamidronate in a girl with chronic renal insufficiency dependent on parenteral nutrition.
Duke JL; Jones DP; Frizzell NK; Chesney RW; Hak EB
Pediatr Nephrol; 2003 Jul; 18(7):714-7. PubMed ID: 12750976
[TBL] [Abstract][Full Text] [Related]
11. Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment.
Yap AS; Hockings GI; Fleming SJ; Khafagi FA
Clin Nephrol; 1990 Nov; 34(5):225-9. PubMed ID: 2268980
[TBL] [Abstract][Full Text] [Related]
12. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
[TBL] [Abstract][Full Text] [Related]
13. Prevention of postoperative osteopenia using IV pamidronate: a pilot study.
Hobby BD; Dominguez-Bartmess S; Szalay EA
J Pediatr Orthop; 2013; 33(7):763-7. PubMed ID: 23872799
[TBL] [Abstract][Full Text] [Related]
14. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
Lee DC; Lee GY
J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
[TBL] [Abstract][Full Text] [Related]
15. Pamidronate increases trabecular bone mineral density in immobilization osteopenia in male rats.
Huuskonen J; Arnala I; Olkkonen H; Alhava E
Ann Chir Gynaecol; 2001; 90(1):37-42. PubMed ID: 11336368
[TBL] [Abstract][Full Text] [Related]
16. Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia.
Body JJ; Louviaux I; Dumon JC
Support Care Cancer; 2000 Sep; 8(5):398-404. PubMed ID: 10975689
[TBL] [Abstract][Full Text] [Related]
17. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).
Oliveri B; Mastaglia SR; Mautalen C; Gravano JC; Pardo Argerich L
Acta Paediatr; 2004 Jul; 93(7):1002-3. PubMed ID: 15303821
[TBL] [Abstract][Full Text] [Related]
18. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
[TBL] [Abstract][Full Text] [Related]
19. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia and childhood cancer: a 7-year experience.
Kerdudo C; Aerts I; Fattet S; Chevret L; Pacquement H; Doz F; Michon J; Garabedian M; Orbach D
J Pediatr Hematol Oncol; 2005 Jan; 27(1):23-7. PubMed ID: 15654274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
